Anti-inflammatory Effect of B-Type Natriuretic Peptide Postconditioning During Myocardial Ischemia–Reperfusion: Involvement of PI3K/Akt Signaling Pathway

Inflammation

Volumn 37, Issue 5, 2014, Pages 1669-1674

  Hu, Gangying ^a,b   Huang, Xingyue ^a,b   Zhang, Kai ^c   Jiang, Hong ^a,b   Hu, Xiaorong ^a,b,c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c HUBEI POLYTECHNIC UNIVERSITY   (China)

Author keywords

B type natriuretic peptide; high mobility group box 1 protein; myocardial ischemia; PI3K Akt; postconditioning; reperfusion

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; IMMUNOBLOTTING; ISCHEMIC POSTCONDITIONING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NATRIURETIC PEPTIDE, BRAIN; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84918767292     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9895-0     Document Type: Article

References (23)

1. Scaffidi, P., T. Misteli, and M.E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191–195.
2. Bell, C.W., W. Jiang, C.F. Reich, et al. 2006. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 291: C1318–C1325.
3. Andrassy, M., H.C. Volz, J.C. Igwe, et al. 2008. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117: 3216–3226.
4. Hu, X., H. Jiang, Q. Bai, et al. 2009. Increased serum HMGB1 is related to the severity of coronary artery stenosis. Clin Chim Acta 406: 139–142.
5. Andrassy, M., H.C. Volz, N. Riedle, et al. 2011. HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med 270: 245–253.
6. Hu, X., W. Zhou, Q. Bai, et al. 2011. Increased serum high mobility group box 1 protein in patients with atrial fibrillation. Biomed Aging Pathol 1: 52–55.
7. Frangoginis, N.G., C.W. Smith, and M.L. Entman. 2002. The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31–47.
8. Hu, X., W. Fu, and H. Jiang. 2012. HMGB1: A potential therapeutic target for myocardial ischemia and reperfusion injury. Int J Cardiol 155: 489–489.
9. Burley, D.S., and G.F. Baxter. 2007. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart. Basic Res Cardiol 102: 529–541.
10. Wu, B., H. Jiang, R. Lin, et al. 2009. Pretreatment with B-type natriuretic peptide protects the heart from ischemia-reperfusion injury by inhibiting myocardial apoptosis. Tohoku J Exp Med 219: 107–114.
11. Ren, B., H. Wu, R. Yin, et al. 2010. B-type natriuretic peptide pretreatment attenuates heart ischemia-reperfusion injury in rats. Transplant Proc 42: 4496–4498.
12. Sun Y, Deng T, Lu N, et al. B-type natriuretic peptide protect cardiomyocytes at reperfusion via mitochondrial calcium uniporter. 2010;64:170–176.
13. Hu, X., X. Zhou, B. He, et al. 2010. Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Eur J Pharmacol 638: 84–89.
14. Hausenloy, D.J., and D.M. Yellon. 2006. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70: 240–253.
15. Gottlieb, R.A., and R.L. Engler. 1999. Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci 68: 412–426.
16. Xiong, J., Y.J. Yuan, F.S. Xue, et al. 2012. Postconditioning with α7nAChR agonist attenuates systemic inflammatory response to myocardial ischemia-reperfusion injury in rats. Inflammation 35: 1357–1364.
17. Tang, D., Y. Shi, R. Kang, et al. 2007. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 81: 741–747.
18. Tsung, A., J.R. Klune, X. Zhang, et al. 2007. HMGB1 release induced by liver ischemia involves toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 204: 2913–2923.
19. Zhang, Z.W., Q.Y. Zhang, M.T. Zhou, et al. 2010. Antioxidant inhibits HMGB1 expression and reduces pancreas injury in rats with severe acute pancreatitis. Dig Dis Sci 55: 2529–2536.
20. Yasuda, T., T. Ueda, Y. Takeyama, et al. 2006. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas 33: 359–363.
21. Sawa, H., T. Ueda, Y. Takeyama, et al. 2006. Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J Gastroenterol 12: 7666–7670.
22. Cantley, L.C. 2002. The phosphoinostide 3-kinase pathway. Science 296: 1655–1657.
23. Ha, Y.M., M.Y. Kim, M.K. Park, et al. 2012. Higenamine reduces HMGB1 during hypoxia-induced brain injury by induction of heme oxygenase-1 through PI3K/Akt/Nrf-2 signal pathways. Apoptosis 17: 463–474.